Genovis AB (FRA:5GV) Beginning Cash Position : €15.47 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Genovis AB Beginning Cash Position?

Genovis AB's Beginning Cash Position for the quarter that ended in Mar. 2025 was €15.47 Mil.

Genovis AB's quarterly Beginning Cash Position increased from Sep. 2024 (€11.96 Mil) to Dec. 2024 (€13.52 Mil) and increased from Dec. 2024 (€13.52 Mil) to Mar. 2025 (€15.47 Mil).

Genovis AB's annual Beginning Cash Position declined from Dec. 2022 (€7.40 Mil) to Dec. 2023 (€6.51 Mil) but then increased from Dec. 2023 (€6.51 Mil) to Dec. 2024 (€10.72 Mil).

Genovis AB Beginning Cash Position Historical Data

The historical data trend for Genovis AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genovis AB Beginning Cash Position Chart

Genovis AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

1.47

4.30

7.40

6.51

10.72

Genovis AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															10.89	12.12	11.96	13.52	15.47

Genovis AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Genovis AB Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Genovis AB's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Genovis AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genovis AB (FRA:5GV) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

GENO:Sweden

Address

Scheelevagen 2, Box 790, Lund, SWE, SE-220 07

Website

https://www.genovis.com

Genovis AB provides enzymes and technologies for the analytical characterization and conjugation of biopharmaceuticals. The principal activities of the company are to develop, produce, and market tools for developing new drugs and diagnostics. Its product line comprises GingisREX, FabRICATOR, GlyCLICK, GingisKHAN, GlycINATOR, Fabulous, lgGZERO, and Enzymes for O-glycan. The company's main product category consists of Enzymes and Antibodies. Geographically its segments include Sweden and the rest of the world.

Genovis AB Headlines

No Headlines